More intensive statin regimens and further LDL reductions yield greater reductions in heart disease events and death risk, with a 20% reduction in CHD death and 10% reduction in all-cause mortality per 1 mmol/L LDL-C reduction.

“Contrary to the observational data, a large meta-analysis showed that more intensive statin regimens and further reductions in LDL cholesterol produced further reductions in heart disease events and death risk. 20% reduction in coronary heart disease death and 10% reduction in all-cause mortality per 1 mmol/L (38.7 mg/dL) LDL-C reduction across trials.”